Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Why The Harvard Funding Case Is 'Clear As Mud' On Appeal No Photo Available

Chris Villani

A sweeping Harvard University victory in a suit challenging President Donald Trump's block on $2.2 billion in grant funding tees up a ... (more story)

Monthly Merger Review Snapshot No Photo Available

Bryan Koenig

The Justice Department settled a challenge to UnitedHealth's $3.3 billion home hospice acquisition while Democrats called for a judge ... (more story)

How Morgan & Morgan Got Ousted As Top Federal Tort Filer No Photo Available

Y. Peter Kang

Heavyweight injury firm Morgan & Morgan PA was ousted from the top spot for most federal court filings in the past three years thanks ... (more story)